Report Detail

Medical Industry COVID-19 Impact on Tuberculosis (TB) Detection Market, Global Research Reports 2020-2021

  • RnM3970590
  • |
  • 18 May, 2020
  • |
  • Global
  • |
  • 94 Pages
  • |
  • QYResearch
  • |
  • Medical Industry

Tuberculosis (TB) is a chronic infection caused by the bacterium tuberculosis (TB).Tuberculous bacterium invades human body all sorts of organs possibly, but basically encroach lung, call tuberculosis disease.
Tuberculosis (TB) is a chronic and slow - onset infectious disease in young people.The incubation period is 4 to 8 weeks.Of these, 80% occur in the lungs, and other areas (cervical lymph, meninges, peritoneum, intestine, skin, bone) may also be secondary to infection.Transmission of respiratory tract from person to person is the main mode of transmission.Infection source is the person that contacts the tuberculosis that discharges bacterium.With the spread of environmental pollution and AIDS, the incidence of TB is becoming more and more intense.In addition to a few cases of rapid onset, clinical more chronic process.There are often low fever, fatigue and other systemic symptoms and respiratory symptoms such as cough, hemoptysis.

This report provides a complete quantitative data and qualitative analysis on the global market for Tuberculosis (TB) Detection. Market size is analysed by country, product type, application, and competitors. Expanded coverage includes additional end-user industry breakdowns and in-depth producer profiles.
Prior to COVID-19, the global market for Tuberculosis (TB) Detection was anticipated to grow from US$ XX million in 2020 to US$ XX million by 2026; it is expected to grow at a CAGR of xx% during 2021–2026, whereas post-COVID-19 scenario, the market for Tuberculosis (TB) Detection is projected to grow from US$ XX million in 2020 (a change by ~XX% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ XX billion by 2026; it is expected to grow at a CAGR of XX% during 2021–2026.
This report covers market size and forecasts of Tuberculosis (TB) Detection, including the following market information:
Global Tuberculosis (TB) Detection Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Tuberculosis (TB) Detection Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Tuberculosis (TB) Detection Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Tuberculosis (TB) Detection Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)

Key market players
Major competitors identified in this market include Danaher, Roche, Thermal Fisher, Abbott, Oxford Immunotec International, Qiagen, Hologic, Hain Lifescience, Epistem, Creative Diagnostics, etc.

Based on the Region:
Asia-Pacific (China, Japan, South Korea, India and ASEAN)
North America (US and Canada)
Europe (Germany, France, UK and Italy)
Rest of World (Latin America, Middle East & Africa)

Based on the Type:
Bacterial Culture Test
Tuberculin Test
Rapid Molecular Diagnosis
Other

Based on the Application:
Hospital
Clinic
Research Institution
Other


  • 1.1 Research Scope
  • 1.2 Market Segmentation
  • 1.3 Research Objectives
  • 1.4 Research Methodology
    • 1.4.1 Research Process
    • 1.4.2 Data Triangulation
    • 1.4.3 Research Approach
    • 1.4.4 Base Year
  • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
    • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.5.2 Covid-19 Impact: Commodity Prices Indices
    • 1.5.3 Covid-19 Impact: Global Major Government Policy
  • 1.6 The Covid-19 Impact on Tuberculosis (TB) Detection Industry
  • 1.7 COVID-19 Impact: Tuberculosis (TB) Detection Market Trends
  • 2 Global Tuberculosis (TB) Detection Quarterly Market Size Analysis

    • 2.1 Tuberculosis (TB) Detection Business Impact Assessment - COVID-19
      • 2.1.1 Global Tuberculosis (TB) Detection Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
    • 2.2 Global Tuberculosis (TB) Detection Quarterly Market Size 2020-2021
    • 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
      • 2.3.1 Drivers
      • 2.3.2 Restraints
      • 2.3.3 Opportunities
      • 2.3.4 Challenges

    3 Quarterly Competitive Assessment, 2020

    • 3.1 By Players, Global Tuberculosis (TB) Detection Quarterly Market Size, 2019 VS 2020
    • 3.2 By Players, Tuberculosis (TB) Detection Headquarters and Area Served
    • 3.3 Date of Key Players Enter into Tuberculosis (TB) Detection Market
    • 3.4 Key Players Tuberculosis (TB) Detection Product Offered
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Impact of Covid-19 on Tuberculosis (TB) Detection Segments, By Type

    • 4.1 Introduction
      • 1.4.1 Bacterial Culture Test
      • 1.4.2 Tuberculin Test
      • 1.4.3 Rapid Molecular Diagnosis
      • 1.4.4 Other
    • 4.2 By Type, Global Tuberculosis (TB) Detection Market Size, 2019-2021

    5 Impact of Covid-19 on Tuberculosis (TB) Detection Segments, By Application

    • 5.1 Overview
      • 5.5.1 Hospital
      • 5.5.2 Clinic
      • 5.5.3 Research Institution
      • 5.5.4 Other
    • 5.2 By Application, Global Tuberculosis (TB) Detection Market Size, 2019-2021
      • 5.2.1 By Application, Global Tuberculosis (TB) Detection Market Size by Application, 2019-2021

    6 Geographic Analysis

    • 6.1 Introduction
    • 6.2 North America
      • 6.2.1 Macroeconomic Indicators of US
      • 6.2.2 US
      • 6.2.3 Canada
    • 6.3 Europe
      • 6.3.1 Macroeconomic Indicators of Europe
      • 6.3.2 Germany
      • 6.3.3 France
      • 6.3.4 UK
      • 6.3.5 Italy
    • 6.4 Asia-Pacific
      • 6.4.1 Macroeconomic Indicators of Asia-Pacific
      • 6.4.2 China
      • 6.4.3 Japan
      • 6.4.4 South Korea
      • 6.4.5 India
      • 6.4.6 ASEAN
    • 6.5 Rest of World
      • 6.5.1 Latin America
      • 6.5.2 Middle East and Africa

    7 Company Profiles

    • 7.1 Danaher
      • 7.1.1 Danaher Business Overview
      • 7.1.2 Danaher Tuberculosis (TB) Detection Quarterly Revenue, 2020
      • 7.1.3 Danaher Tuberculosis (TB) Detection Product Introduction
      • 7.1.4 Danaher Response to COVID-19 and Related Developments
    • 7.2 Roche
      • 7.2.1 Roche Business Overview
      • 7.2.2 Roche Tuberculosis (TB) Detection Quarterly Revenue, 2020
      • 7.2.3 Roche Tuberculosis (TB) Detection Product Introduction
      • 7.2.4 Roche Response to COVID-19 and Related Developments
    • 7.3 Thermal Fisher
      • 7.3.1 Thermal Fisher Business Overview
      • 7.3.2 Thermal Fisher Tuberculosis (TB) Detection Quarterly Revenue, 2020
      • 7.3.3 Thermal Fisher Tuberculosis (TB) Detection Product Introduction
      • 7.3.4 Thermal Fisher Response to COVID-19 and Related Developments
    • 7.4 Abbott
      • 7.4.1 Abbott Business Overview
      • 7.4.2 Abbott Tuberculosis (TB) Detection Quarterly Revenue, 2020
      • 7.4.3 Abbott Tuberculosis (TB) Detection Product Introduction
      • 7.4.4 Abbott Response to COVID-19 and Related Developments
    • 7.5 Oxford Immunotec International
      • 7.5.1 Oxford Immunotec International Business Overview
      • 7.5.2 Oxford Immunotec International Tuberculosis (TB) Detection Quarterly Revenue, 2020
      • 7.5.3 Oxford Immunotec International Tuberculosis (TB) Detection Product Introduction
      • 7.5.4 Oxford Immunotec International Response to COVID-19 and Related Developments
    • 7.6 Qiagen
      • 7.6.1 Qiagen Business Overview
      • 7.6.2 Qiagen Tuberculosis (TB) Detection Quarterly Revenue, 2020
      • 7.6.3 Qiagen Tuberculosis (TB) Detection Product Introduction
      • 7.6.4 Qiagen Response to COVID-19 and Related Developments
    • 7.7 Hologic
      • 7.7.1 Hologic Business Overview
      • 7.7.2 Hologic Tuberculosis (TB) Detection Quarterly Revenue, 2020
      • 7.7.3 Hologic Tuberculosis (TB) Detection Product Introduction
      • 7.7.4 Hologic Response to COVID-19 and Related Developments
    • 7.8 Hain Lifescience
      • 7.8.1 Hain Lifescience Business Overview
      • 7.8.2 Hain Lifescience Tuberculosis (TB) Detection Quarterly Revenue, 2020
      • 7.8.3 Hain Lifescience Tuberculosis (TB) Detection Product Introduction
      • 7.8.4 Hain Lifescience Response to COVID-19 and Related Developments
    • 7.9 Epistem
      • 7.9.1 Epistem Business Overview
      • 7.9.2 Epistem Tuberculosis (TB) Detection Quarterly Revenue, 2020
      • 7.9.3 Epistem Tuberculosis (TB) Detection Product Introduction
      • 7.9.4 Epistem Response to COVID-19 and Related Developments
    • 7.10 Creative Diagnostics
      • 7.10.1 Creative Diagnostics Business Overview
      • 7.10.2 Creative Diagnostics Tuberculosis (TB) Detection Quarterly Revenue, 2020
      • 7.10.3 Creative Diagnostics Tuberculosis (TB) Detection Product Introduction
      • 7.10.4 Creative Diagnostics Response to COVID-19 and Related Developments

    8 Key Findings

      9 Appendix

      • 9.1 About US

      Summary:
      Get latest Market Research Reports on Tuberculosis (TB) Detection. Industry analysis & Market Report on Tuberculosis (TB) Detection is a syndicated market report, published as COVID-19 Impact on Tuberculosis (TB) Detection Market, Global Research Reports 2020-2021. It is complete Research Study and Industry Analysis of Tuberculosis (TB) Detection market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,500.00
      $7,000.00
      2,789.50
      5,579.00
      3,251.50
      6,503.00
      535,255.00
      1,070,510.00
      291,970.00
      583,940.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report